Dabrafenib + Trametinib for cancer treatmentz
Dear Airedale NHS Foundation Trust,
Please answer these questions relating to the usage of Dabrafenib + Trametinib in cancer treatment.
A) Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib:
i) Metastatic Melanoma
ii) Adjuvant Melanoma
iii) BRAF mutated Lung Cancer
I sincerely thank you for taking the time to answer these questions.
Yours faithfully,
David Elder
Dear Mr Elder
Thank you for your request for information from Airedale NHS Foundation
Trust which was received on 29^th June 2022. Please accept my apologies
for the late acknowledgment of receipt. Your request has been given the
Reference Number ANHSFT REF 5810.
We will now proceed to process the request. The deadline date for issuing
you with a full response is 27^th July 2022. We will try to respond to
you before this date and we will contact you if we envisage delays or if
we need more information from you.
Please note that under the Freedom of Information Act, some information
can be subject to exemptions, which means that the Trust does not have to
provide the information requested. Some exemptions are “absolute” such as
personal information and some only apply where the “public interest” in
maintaining the exemption, outweighs that of providing the information.
In some cases, where identifying, retrieving and processing the requested
information requires more time than the “appropriate cost limit” of two
and half days work, we may refuse the request or we can charge a fee. If
the latter is the case, I will let you know and a Fees Notice will be
issued to you. In that case you would need to pay the fee before we
proceeded with your request, but we will offer assistance and advise you
if, by modifying your request, we could provide you with some non-exempt
or free of charge information.
Please contact me, quoting the Reference Number above, with any questions
you might have about your request.
With kind regards
Deborah Cocker
FOI Administrator
Airedale NHS Foundation Trust, Steeton, KEIGHLEY, BD20 6TD
Location: IT Business Centre | Zone C | Department 48
My usual working pattern is Mon-Thurs and I am currently working from home
[1]http://www.airedale-trust.nhs.uk / Follow us on Twitter
[2]@AiredaleNHSFT
Dear Mr Elder
Further to your application to access information under the Freedom of
Information Act (ANHSFT REF. 5810) please find our response below.
We don’t treat the two conditions below at this Trust.
i) Metastatic Melanoma
ii) Adjuvant Melanoma
We might treat BRAF mutated lung cancer, but we have never used Dabrafenib
/ Trametinib
We trust you find our response helpful. If you feel we are not complying
with our publication scheme, you feel your request has not been properly
handled, or you are dissatisfied, you can write within 40 working days to
Foluke Ajayi, Chief Executive at the address below to request a review.
You also have the right to complain to the Information Commissioner under
section 50 of the Freedom of Information Act 2000 if you are dissatisfied
with the outcome of that review.
Unless identified as another party's copyright, you may use and re-use the
information we have provided (not including logos or photographs), free of
charge in any format or medium, under the terms of the Open Government
Licence which can be viewed via the link below.
[1]http://www.nationalarchives.gov.uk/doc/o...
Yours sincerely
Deborah Cocker
FOI/IG Asst
Airedale NHS Foundation Trust, Steeton, KEIGHLEY, BD20 6TD
Location: IT Business Centre | Zone C | Department 48
My usual working pattern is Mon-Thurs and I am currently working from home
[2]http://www.airedale-trust.nhs.uk / Follow us on Twitter
[3]@AiredaleNHSFT
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now